Service d'urologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


503 publications

Sous presse | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ...
 
Reduction and follow-up of hospital discharge letter delay using Little's law.
Burruni R., Cuany B., Valerio M., Jichlinski P., Kulik G. International journal for quality in health care. Peer-reviewed.
 
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
Derré L., Lucca I., Cesson V., Valerio M., Cerantola Y., Burruni R., Fritschi U., Gharbi D., Bobst M., Legris A.S. et al. European urology focus. Peer-reviewed.
 
Identification of ureteral stones at reduced radiation exposure: a pilot study comparing conventional versus digital low-dosage linear slot scanning (Lodox<sup>®</sup>) radiography.
Fiechter S., Geissbühler E., Bähler A., Obmann V., Meierhans S., Exadaktylos A.K., Christe A., Thalmann G.N., Roth B. World journal of urology. Peer-reviewed.
 
Imaging modalities in synchronous oligometastatic prostate cancer.
Futterer J.J., Surcel C., van den Bergh R., Borgmann H., Briganti A., Gandaglia G., Kretschmer A., Ost P., Sooriakumaran P., Tilki D. et al., 2019/12. World journal of urology, 37 (12) pp. 2573-2583. Peer-reviewed.
 
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cells.
Mastelic-Gavillet B., Navarro Rodrigo B., Décombaz L., Wang H., Ercolano G., Ahmed R., Lozano L.E., Ianaro A., Derré L., Valerio M. et al., 2019/10/10. Journal for immunotherapy of cancer, 7 (1) p. 257. Peer-reviewed.
 
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
Ploussard G., Gandaglia G., Borgmann H., de Visschere P., Heidegger I., Kretschmer A., Mathieu R., Surcel C., Tilki D., Tsaur I. et al., 2019/10. European urology, 76 (4) pp. 493-504. Peer-reviewed.
 
The multifaceted immune regulation of bladder cancer.
Schneider A.K., Chevalier M.F., Derré L., 2019/10. Nature reviews. Urology, 16 (10) pp. 613-630. Peer-reviewed.
 
Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.
Kasivisvanathan V., Stabile A., Neves J.B., Giganti F., Valerio M., Shanmugabavan Y., Clement K.D., Sarkar D., Philippou Y., Thurtle D. et al., 2019/09. European urology, 76 (3) pp. 284-303. Peer-reviewed.
 
Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Marra G., Valerio M., Emberton M., Heidenreich A., Crook J.M., Bossi A., Pisters L.L., 2019/09. European urology oncology, 2 (5) pp. 526-538. Peer-reviewed.
 
Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Schneider M.P., Tornic J., Sýkora R., Abo Youssef N., Mordasini L., Krhut J., Chartier-Kastler E., Davies M., Gajewski J., Schurch B. et al., 2019/08. Neurourology and urodynamics, 38 (6) pp. 1482-1491. Peer-reviewed.
 
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
Shah T.T., Peters M., Eldred-Evans D., Miah S., Yap T., Faure-Walker N.A., Hosking-Jervis F., Thomas B., Dudderidge T., Hindley R.G. et al., 2019/07. European urology, 76 (1) pp. 98-105. Peer-reviewed.
 
Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria.
Lucca I., Hofbauer S.L., Haitel A., Susani M., Shariat S.F., Klatte T., De Martino M., 2019/07. Oncology letters, 18 (1) pp. 57-62. Peer-reviewed.
 
Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F., Fiori C., Amparore D., Kadner G., Manit A., Valerio M., Nicolaas L., Ho BSH, Alonso S., Schulman C. et al., 2019/06. BJU international, 123 (6) pp. 1061-1069. Peer-reviewed.
 
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors.
Domingos-Pereira S., Galliverti G., Hanahan D., Nardelli-Haefliger D., 2019/05/06. Journal for immunotherapy of cancer, 7 (1) p. 122. Peer-reviewed.
 
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Tsaur I., Heidegger I., Kretschmer A., Borgmann H., Gandaglia G., Briganti A., de Visschere P., Mathieu R., Valerio M., van den Bergh R. et al., 2019/05. Cancer treatment reviews, 75 pp. 20-26. Peer-reviewed.
 
Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model.
Domingos-Pereira S., Sathiyanadan K., La Rosa S., Polák L., Chevalier M.F., Martel P., Hojeij R., Derré L., Haefliger J.A., Jichlinski P. et al., 2019/04. Cancer immunology research, 7 (4) pp. 621-629. Peer-reviewed.
 
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G., Ploussard G., Valerio M., Mattei A., Fiori C., Fossati N., Stabile A., Beauval J.B., Malavaud B., Roumiguié M. et al., 2019/03. European urology, 75 (3) pp. 506-514. Peer-reviewed.
 
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
van den Bergh R., Gandaglia G., Tilki D., Borgmann H., Ost P., Surcel C., Valerio M., Sooriakumaran P., Salomon L., Briganti A. et al., 2019/03. European urology focus, 5 (2) pp. 171-178. Peer-reviewed.
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
 
Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
Marra G., Ploussard G., Futterer J., Valerio M., EAU-YAU Prostate Cancer Working Party, 2019/02. World journal of urology, 37 (2) pp. 277-287. Peer-reviewed.
 
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
Ploussard G., Borgmann H., Briganti A., de Visschere P., Fütterer J.J., Gandaglia G., Heidegger I., Kretschmer A., Mathieu R., Ost P. et al., 2019/02. World journal of urology, 37 (2) pp. 243-251. Peer-reviewed.
 
Re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
Valerio M., Emberton M., Ahmed H.U., 2019/02. European urology, 75 (2) pp. e21-e22. Peer-reviewed.
 
The pro- and anti-tumor role of ILC2s.
Trabanelli S., Chevalier M.F., Derré L., Jandus C., 2019/02. Seminars in immunology, 41 p. 101276. Peer-reviewed.
 
Version courte des recommandations de la récupération ameliorée après chirurgie (RAAC) pour la cystectomie : mesures techniques [Short version of recommendations for enhanced recovery program (ERP) for cystectomy: Technical measures]
Poinas G., Blache J.L., Kassab-Chahmi D., Evrard P.L., Artus P.M., Alfonsi P., Rébillard X., Beaussier M., Cerantola Y., Coloby P. et al., 2019/02. Progres en urologie, 29 (2) pp. 63-75. Peer-reviewed.
 
Urologie [Urology in 2018]
Jichlinski P., 2019/01/16. Revue medicale suisse, 15 (634) pp. 167-169. Peer-reviewed.
 
A structural model of the immune checkpoint CD160-HVEM complex derived from HDX-mass spectrometry and molecular modeling.
Kuncewicz K., Spodzieja M., Sieradzan A., Karczyńska A., Dąbrowska K., Dadlez M., Speiser D.E., Derre L., Rodziewicz-Motowidło S., 2019/01/11. Oncotarget, 10 (4) pp. 536-550. Peer-reviewed.
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.
Bohner P., Chevalier M.F., Cesson V., Rodrigues-Dias S.C., Dartiguenave F., Burruni R., Tawadros T., Valerio M., Lucca I., Nardelli-Haefliger D. et al., 2019. Frontiers in immunology, 10 p. 622. Peer-reviewed.
 
Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey.
Marra G., Ploussard G., Ost P., De Visschere PJL, Briganti A., Gandaglia G., Tilki D., Surcel C.I., Tsaur I., Van Den Bergh RCN et al., 2018/12. Urologic oncology, 36 (12) pp. 529.e11-529.e22. Peer-reviewed.
 
Changement de pratique en urologie et dans le monde de la santé : les bienfaits de la prise de recul []
Jichlinski P., Iselin C.E., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2147-2148. Peer-reviewed.
 
Chirurgie ambulatoire en urologie : il est temps d’en parler [Ambulatory surgery in urology]
Haverdings H., Vola F., Altwegg G., Chollet M., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2164-2166. Peer-reviewed.
 
Indications à un bilan urodynamique et à une antibioprophylaxie avant celui-ci [About the indications to urodynamic studies and to a prior antibioprophylaxy]
Micol L.A., Rakauskas A., Schurch B., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2167-2171. Peer-reviewed.
 
Réhabilitation améliorée après chirurgie urologique majeure : quel rôle pour le médecin généraliste ? [Improved rehabilitation after major urological surgery : what role for the general practitioner ?]
Martel P., Crettenand F., M'baya O., Cerantola Y., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2150-2153. Peer-reviewed.
 
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy.
Chevalier M.F., Schneider A.K., Cesson V., Dartiguenave F., Lucca I., Jichlinski P., Nardelli-Haefliger D., Derré L., 2018/11. European urology, 74 (5) pp. 540-544. Peer-reviewed.
 
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.
Gandaglia G., van den Bergh RCN, Tilki D., Fossati N., Ost P., Surcel C.I., Sooriakumaran P., Tsaur I., Valerio M., Kretschmer A. et al., 2018/11. BJU international, 122 (5) pp. 823-830. Peer-reviewed.
 
Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice.
Galliverti G., Tichet M., Domingos-Pereira S., Hauert S., Nardelli-Haefliger D., Swartz M.A., Hanahan D., Wullschleger S., 2018/11. Cancer immunology research, 6 (11) pp. 1301-1313. Peer-reviewed.
 
Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology.
van den Bergh RCN, Ost P., Surcel C., Valerio M., Fütterer J.J., Gandaglia G., Sooriakumaran P., Tilki D., Tsaur I., Ploussard G. et al., 2018/09. World journal of urology, 36 (9) pp. 1489-1494. Peer-reviewed.
 
Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy.
Rentsch C.A., Derré L., Dugas S.G., Wetterauer C., Federer-Gsponer J.R., Thalmann G.N., Ingersoll M.A., 2018/07. European urology focus, 4 (4) pp. 485-493. Peer-reviewed.
 
Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer.
Alvarez-Arguedas S., Uranga S., Martín M., Elizalde J., Gomez A.B., Julián E., Nardelli-Haefliger D., Martín C., Aguilo N., 2018/07. Translational research, 197 pp. 32-42. Peer-reviewed.
 
New technologies and techniques for prostate cancer focal therapy.
Linares-Espinós E., Carneiro A., Martínez-Salamanca J.I., Bianco F., Castro-Alfaro A., Cathelineau X., Valerio M., Sanchez-Salas R., 2018/06. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 70 (3) pp. 252-263. Peer-reviewed.
 
Re: Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy: I. Nunes-Silva, E. Barret, V. Srougi, M. Baghdadi, P. Capogrosso, S. Garcia-Barreras, S. Kanso, R. Tourinho-Barbosa, A. Carneiro, R. Sanchez-Salas, F. Rozet, M. Galiano and X. Cathelineau J Urol 2017;198:1069-1076.
Shah T.T., Valerio M., Ahmed H.U., 2018/06. The Journal of urology, 199 (6) pp. 1634-1635. Peer-reviewed.
 
L’application d’un programme de réhabilitation précoce (ERAS) améliore-t-elle les résultats périopératoires après cystectomie ? [Do initial experience with an enhanced recovery program after surgery (ERAS) improve postoperative outcomes after cystectomy?]
Baldini A., Fassi Fehri H., Cerantola Y., Bayle F., Ravier E., Belot P.Y., Arnouil N., Colombel M., Badet L., 2018/05. Progres en urologie, 28 (6) pp. 351-358. Peer-reviewed.
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.
Bobisse S., Genolet R., Roberti A., Tanyi J.L., Racle J., Stevenson B.J., Iseli C., Michel A., Le Bitoux M.A., Guillaume P. et al., 2018/03/15. Nature communications, 9 (1) p. 1092. Peer-reviewed.
 
Multiparametric prostate MRI: technical conduct, standardized report and clinical use.
Manfredi M., Mele F., Garrou D., Walz J., Fütterer J.J., Russo F., Vassallo L., Villers A., Emberton M., Valerio M., 2018/02. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 70 (1) pp. 9-21. Peer-reviewed.
 
Urologie [Urology]
Jichlinski P., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 97-99. Peer-reviewed.
Occurrence and prognosis of lymph node metastases in patients selected for isolated limb perfusion with soft tissue sarcoma.
Crettenand F., Martin D., Cherix S., Demartines N., Matter M., 2018. Journal of Cancer, 9 (18) pp. 3311-3315. Peer-reviewed.
 
Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET/CT: An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma.
Van Der Gucht A., Maged Z., Burruni R., Barras J.L., Schaefer N., 2018/01. Clinical nuclear medicine, 43 (1) pp. 41-43. Peer-reviewed.
 
Ablation du cancer primaire dans les néoplasies urologiques oligométastatiques : évidence ou vœux pieux ? [Local treatment in oligometastatic urological malignancies : evidence of wishful thinking ?]
Valerio M., Cerantola Y., Lucca I., Berthold D., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2083-2086. Peer-reviewed.
 
Immunonutrition en uro-oncologie : entre mythe et réalité [Myths and reality about immunonutrition in uro-oncology]
Cerantola Y., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2079-2082. Peer-reviewed.
Immunothérapie : une révolution dans la prise en charge du cancer de la vessie ? [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
Adam S.M., Derré L., Jichlinski P., Lucca I., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2074-2078. Peer-reviewed.
 
Urologie évolutive : par X, Y et Z… et encore ! []
Iselin C.E., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) p. 2067. Peer-reviewed.
 
Eye lens radiation exposure of the medical staff performing interventional urology procedures with an over-couch X-ray tube.
Medici S., Pitzschke A., Cherbuin N., Boldini M., Sans-Merce M., Damet J., 2017/11. Physica medica, 43 pp. 140-147. Peer-reviewed.
 
Targeting Cx40 (Connexin40) Expression or Function Reduces Angiogenesis in the Developing Mouse Retina.
Haefliger J.A., Allagnat F., Hamard L., Le Gal L., Meda P., Nardelli-Haefliger D., Génot E., Alonso F., 2017/11. Arteriosclerosis, thrombosis, and vascular biology, 37 (11) pp. 2136-2146. Peer-reviewed.
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
Trabanelli S., Chevalier M.F., Martinez-Usatorre A., Gomez-Cadena A., Salomé B., Lecciso M., Salvestrini V., Verdeil G., Racle J., Papayannidis C. et al., 2017/09/19. Nature communications, 8 (1) p. 593. Peer-reviewed.
 
Inguinal Bladder Hernia With Acute Ureteral Obstruction 14 Years After Kidney Transplantation: A Case Report.
Ghielmini E., Julita L., Cerantola Y., Matter M., Zingg T., 2017/09. Transplantation proceedings, 49 (7) pp. 1593-1595. Peer-reviewed.
 
Carcinome urothélial de la vessie et des voies urinaires hautes
Julita Loïc, Jichlinski Patrice, Lucca Ilaria, 2017/08/30. Forum Médical Suisse ‒ Swiss Medical Forum, 17 (35). Peer-reviewed.
 
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
Soria F., Lucca I., Moschini M., Mathieu R., Rouprêt M., Karakiewicz P.I., Briganti A., Rink M., Gust K.M., Hassler M.R. et al., 2017/06. Urologic oncology, 35 (6) pp. 356-362. Peer-reviewed.
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.
Chevalier M.F., Bohner P., Pieraerts C., Lhermitte B., Gourmaud J., Nobile A., Rotman S., Cesson V., Martin V., Legris A.S. et al., 2017/06. European urology, 71 (6) pp. 854-857. Peer-reviewed.
 
Does teaching of robotic partial nephrectomy affect renal function and perioperative outcomes?
Cerantola Y., Ploussard G., Kassouf W., Anidjar M., Bladou F., 2017/05. Urologic oncology, 35 (5) pp. 227-233. Peer-reviewed.
 
Focal therapy as primary treatment for localized prostate cancer: definition, needs and future.
Ouzzane A., Betrouni N., Valerio M., Rastinehad A., Colin P., Ploussard G., 2017/04. Future oncology, 13 (8) pp. 727-741. Peer-reviewed.
 
Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M., Shah T.T., Shah P., Mccartan N., Emberton M., Arya M., Ahmed H.U., 2017/04. Urologic oncology, 35 (4) pp. 150.e1-150.e7. Peer-reviewed.
 
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
Valerio M., Dickinson L., Ali A., Ramachadran N., Donaldson I., Mccartan N., Freeman A., Ahmed H.U., Emberton M., 2017/03. The Journal of urology, 197 (3 Pt 1) pp. 647-654. Peer-reviewed.
 
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L., Cesson V., Lucca I., Cerantola Y., Valerio M., Fritschi U., Vlamopoulos Y., Burruni R., Legris A.S., Dartiguenave F. et al., 2017/02/01. Clinical cancer research, 23 (3) pp. 717-725. Peer-reviewed.
 
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study.
Mathieu R., Lucca I., Vartolomei M.D., Mbeutcha A., Klatte T., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y. et al., 2017/02. BJU international, 119 (2) pp. 234-238. Peer-reviewed.
 
Urologie [Urology : therapeutics news in 2016]
Jichlinski P., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 110-111. Peer-reviewed.
Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
Spodzieja M., Lach S., Iwaszkiewicz J., Cesson V., Kalejta K., Olive D., Michielin O., Speiser D.E., Zoete V., Derré L. et al., 2017. PloS one, 12 (6) pp. e0179201.
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
Chevalier M.F., Trabanelli S., Racle J., Salomé B., Cesson V., Gharbi D., Bohner P., Domingos-Pereira S., Dartiguenave F., Fritschi A.S. et al., 2017. The Journal of Clinical Investigation, 127 (8) pp. 2916-2929. Peer-reviewed.
 
Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intent.
Gauvin S., Cerantola Y., Haberer E., Pelsser V., Probst S., Bladou F., Anidjar M., 2017. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 11 (1-2) pp. 47-52. Peer-reviewed.
 
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M., Cerantola Y., Eggener S.E., Lepor H., Polascik T.J., Villers A., Emberton M., 2017/01. European urology, 71 (1) pp. 17-34. Peer-reviewed.
 
Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Jacqmin D., Jichlinski P., Molinier L., de la Taille A., Irani J., Malavaud B., 2017. Urologia internationalis, 99 (3) pp. 358-366. Peer-reviewed.
 
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
Domingos-Pereira S., Cesson V., Chevalier M.F., Derré L., Jichlinski P., Nardelli-Haefliger D., 2017. Oncoimmunology, 6 (1) pp. e1265720. Peer-reviewed.
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei M.D., Mathieu R., Margulis V., Karam J.A., Rouprêt M., Lucca I., Mbeutcha A., Seitz C., Karakiewicz P.I., Fajkovic H. et al., 2017/01. World journal of urology, 35 (1) pp. 121-130. Peer-reviewed.
 
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey.
Bultijnck R., Surcel C., Ploussard G., Briganti A., De Visschere P., Fütterer J., Ghadjar P., Giannarini G., Isbarn H., Massard C. et al., 2016/12. European urology focus, 2 (5) pp. 514-521. Peer-reviewed.
 
Bilan et traitements des infections urogénitales [Assessment and treatment of genitourinary infections]
Martel P., M'Baya O., Senn L., Jichlinski P., Cerantola Y., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2054-2059. Peer-reviewed.
 
Médicaments usuels en médecine de premier recours et cancer de la prostate : quelle relation ? [Common medications and prostate cancer : what is the association ?]
Rakauskas A., Grilo N., M'Baya O., Jichlinski P., Valerio M., Berthold D., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2068-2071. Peer-reviewed.
 
Prise en charge des traumatismes urogénitaux [Management of genitourinary trauma]
Perrin A., Grilo N., Meuwly J.Y., Jichlinski P., Valerio M., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2072-2076. Peer-reviewed.
 
Vers une réforme « concertée » de l’incitatif financier dans le système de santé ?
Jichlinski P., Iselin C.E., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2051-2052. Peer-reviewed.
 
Le traitement standard du cancer de la vessie non musculo-invasif avec du BCG peut être associé à une vaccination anti-cancer pour augmenter la réponse vaccinale cellulaire T locale
Jichlinski P., Derré L., Nardell-Haefliger D., Speiser D., Romero P., 2016/11., Société française d'urologie p. 705 dans 110e Congrès français d'urologie, Progrès en Urologie.
 
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Mbeutcha A., Shariat S.F., Rieken M., Rink M., Xylinas E., Seitz C., Lucca I., Mathieu R., Rouprêt M., Briganti A. et al., 2016/11. Urologic oncology, 34 (11) pp. 483.e17-483.e24. Peer-reviewed.
 
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Fajkovic H., Shariat S.F., Klatte T., Vartolomei M.D., Lucca I., Mbeutcha A., Rouprêt M., Briganti A., Karakiewicz P.I., Margulis V. et al., 2016/10. World journal of urology, 34 (10) pp. 1411-1419. Peer-reviewed.
 
Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I., Hofbauer S.L., Leitner C.V., de Martino M., Özsoy M., Susani M., Shariat S.F., Klatte T., 2016/09. Urology, 95 pp. 132-138. Peer-reviewed.
 
IGF-1-containing multi-layered collagen-fibrin hybrid scaffolds for bladder tissue engineering.
Vardar E., Larsson H.M., Engelhardt E.M., Pinnagoda K., Briquez P.S., Hubbell J.A., Frey P., 2016/09/01. Acta biomaterialia, 41 pp. 75-85. Peer-reviewed.
The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.
El-Shater Bosaily A., Valerio M., Hu Y., Freeman A., Jameson C., Brown L., Kaplan R., Hindley R.G., Barratt D., Emberton M. et al., 2016/09. Prostate cancer and prostatic diseases, 19 (3) pp. 258-263. Peer-reviewed.
 
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
Mbeutcha A., Lucca I., Margulis V., Karam J.A., Wood C.G., de Martino M., Mathieu R., Haitel A., Xylinas E., Kluth L. et al., 2016/08. World journal of urology, 34 (8) pp. 1155-1161. Peer-reviewed.
 
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.
Mathieu R., Lucca I., Rouprêt M., Briganti A., Shariat S.F., 2016/08. Nature reviews. Urology, 13 (8) pp. 471-479. Peer-reviewed.
 
Cambiando la vía de manejo del cáncer de próstata: ¿Por qué la Terapia Focal es un paso adelante? [Changing the prostate cancer management pathway: why Focal Therapy is a step forward]
Marra G., Gontero P., Valerio M., 2016/07. Archivos espanoles de urologia, 69 (6) pp. 271-280. Peer-reviewed.
 
Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Lucca I., Shariat S.F., 2016/07. European urology, 70 (1) pp. 205-206. Peer-reviewed.
 
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H., Mathieu R., Lucca I., Hiess M., Hübner N., Al Hussein Al Awamlh B., Lee R., Briganti A., Karakiewicz P., Lotan Y. et al., 2016/05. Urologic oncology, 34 (5) pp. 233.e1-6. Peer-reviewed.
 
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis.
Lucca I., Jichlinski P., Shariat S.F., Rouprêt M., Rieken M., Kluth L.A., Rink M., Mathieu R., Mbeutcha A., Maj-Hes A. et al., 2016/04. European urology focus, 2 (1) pp. 79-85. Peer-reviewed.
 
The role of minimally invasive surgery on enhanced recovery after nephrectomy
M'Baya Olivier, Grilo Nuno, Valerio Massimo, Dartiguenave Florence, Puricel Serban, Blanc Catherine, Jichlinski Patrice, Cerantola Yannick, 2016/04. pp. e52 dans Clinical Nutrition ESPEN.
Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion.
Alonso F., Domingos-Pereira S., Le Gal L., Derré L., Meda P., Jichlinski P., Nardelli-Haefliger D., Haefliger J.A., 2016/03/22. Oncotarget, 7 (12) pp. 14015-14028. Peer-reviewed.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James N.D., Sydes M.R., Clarke N.W., Mason M.D., Dearnaley D.P., Spears M.R., Ritchie A.W., Parker C.C., Russell J.M., Attard G. et al., 2016/03/19. Lancet (London, England), 387 (10024) pp. 1163-1177. Peer-reviewed.
Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
Hojeij R., Domingos-Pereira S., Nkosi M., Gharbi D., Derré L., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2016/03/14. International journal of molecular sciences, 17 (7) pp. E1125. Peer-reviewed.
 
Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
Cerantola Y., Haberer E., Torres J., Alameldin M., Aronson S., Levental M., Bladou F., Anidjar M., 2016/01. World journal of urology, 34 (1) pp. 75-82. Peer-reviewed.
 
Addressing overtreatment following the diagnosis of localized prostate cancer.
Tawadros T., Valerio M., 2016. Expert Review of Anticancer Therapy, 16 (4) pp. 373-374. Peer-reviewed.
 
Analyse de l’infiltration immunitaire au cours des instillations intravésicales de BCG : identification d’un profil immunosuppressif prédictif de la récidive tumorale
Chevalier M., Trabanelli S., Gharbi D., Cesson V., Domingos-Pereira S., Dartiguenave F., Fritschi A., Speiser D., Romero P., Jandus C. et al., 2016., Société française d'urologie p. 707 dans 110e Congrès français d'urologie, Progres en urologie .
 
Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer.
Cerantola Y., Dragomir A., Tanguay S., Bladou F., Aprikian A., Kassouf W., 2016. Urologic Oncology, 34 (3) pp. 119.e1-119.e9. Peer-reviewed.
 
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
Mbeutcha A., Lucca I., Mathieu R., Lotan Y., Shariat S.F., 2016. Urologic Clinics of North America, 43 (1) pp. 47-62. Peer-reviewed.
 
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study.
Mathieu R., Klatte T., Lucca I., Mbeutcha A., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y., Scherr D.S. et al., 2016. Bju International, 118 (2) pp. 243-249. Peer-reviewed.
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.
De Visschere P.J., Briganti A., Fütterer J.J., Ghadjar P., Isbarn H., Massard C., Ost P., Sooriakumaran P., Surcel C.I., Valerio M. et al., 2016. Insights Into Imaging, 7 (2) pp. 205-214. Peer-reviewed.
 
Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy.
Weiss L., Chevalier M.F., Assoumou L., Paul J.L., Alhenc-Gelas M., Didier C., Taibi S., Manea E.M., Campa P., Girard P.M. et al., 2016. Journal of Acquired Immune Deficiency Syndromes (1999), 71 (4) pp. 390-398. Peer-reviewed.
 
The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping Biopsies.
Valerio M., Anele C., Bott S.R., Charman S.C., van der Meulen J., El-Mahallawi H., Emara A.M., Freeman A., Jameson C., Hindley R.G. et al., 2016. Journal of Urology, 195 (5) pp. 1403-1408. Peer-reviewed.
 
The role of renal biopsy in small renal masses.
Burruni R., Lhermitte B., Cerantola Y., Tawadros T., Meuwly J.Y., Berthold D., Jichlinski P., Valerio M., 2016. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10 (1-2) pp. E28-33. Peer-reviewed.
 
Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer.
Valerio M., Anele C., Charman S.C., van der Meulen J., Freeman A., Jameson C., Singh P.B., Emberton M., Ahmed H.U., 2016. Bju International, 118 (3) pp. 384-390. Peer-reviewed.
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8(+) and CD4(+) T-cell responses with multiple specificities including a novel DR7-restricted epitope.
Baumgaertner P., Costa Nunes C., Cachot A., Maby-El Hajjami H., Cagnon L., Braun M., Derré L., Rivals J.P., Rimoldi D., Gnjatic S. et al., 2016. Oncoimmunology, 5 (10) pp. e1216290. Peer-reviewed.
 
Incontinence urinaire chez la femme âgée: que faire au cabinet? [Urinary incontinence in older women: what can a GP do?]
Ernst V., Saïah L., Cerantola Y., Bosshard Taroni W., Haftgoli N., Büla C., 2015/11/11. Revue medicale suisse, 11 (494) pp. 2104,2106-2109. Peer-reviewed.
 
Cancer testiculaire: un modèle pour optimiser le suivi radiologique [Testicular cancer: a model to optimize the radiological follow-up].
Stebler V., Pauchard B., Schmidt S., Valerio M., De Bari B., Berthold D., 2015/05. Revue Médicale Suisse, 11 (475) pp. 1144-1148.
 
A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer.
Willis S.R., van der Meulen J., Valerio M., Miners A., Ahmed H.U., Emberton M., 2015. Current Opinion In Urology, 25 (6) pp. 483-489. Peer-reviewed.
 
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I., Rouprêt M., Kluth L., Rink M., Tilki D., Fajkovic H., Kassouf W., Hofbauer S.L., de Martino M., Karakiewicz P.I. et al., 2015. Bju International, 115 (5) pp. 722-727. Peer-reviewed.
 
Biopsies de la prostate en 2015: quelle biopsie pour quel patient [Prostate biopsy: which strategy for which patient?].
Burruni R., Cerantola Y., Meuwly J.Y., Tawadros T., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (497) pp. 2288-90, 2292.
 
Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.
Lucca I., de Martino M., Hofbauer S.L., Zamani N., Shariat S.F., Klatte T., 2015. World Journal of Urology, 33 (12) pp. 2045-2052. Peer-reviewed.
 
Compliance with preoperative oral nutritional supplements in patients at nutritional risk─only a question of will?
Grass F., Bertrand P.C., Schäfer M., Ballabeni P., Cerantola Y., Demartines N., Hübner M., 2015. European Journal of Clinical Nutrition, 69 (4) pp. 525-529. Peer-reviewed.
 
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
Valerio M., Donaldson I., Emberton M., Ehdaie B., Hadaschik B.A., Marks L.S., Mozer P., Rastinehad A.R., Ahmed H.U., 2015. European Urology, 68 (1) pp. 8-19. Peer-reviewed.
 
Diagnosis and Management of Upper Tract Urothelial Carcinoma.
Lucca I., Leow J.J., Shariat S.F., Chang S.L., 2015. Hematology/oncology Clinics of North America, 29 (2) pp. 271-288. Peer-reviewed.
 
Dysfunction of lower urinary tract in patients with spinal cord injury.
Schurch B., Tawadros C., Carda S., 2015. Handbook of Clinical Neurology, 130 pp. 247-267. Peer-reviewed.
 
External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.
Tawadros C., Burnett K., Derbyshire L.F., Tawadros T., Clarke N.W., Betts C.D., 2015. Bju International, 116 (3) pp. 423-431. Peer-reviewed.
 
Focal Therapy of Prostate Cancer Using Irreversible Electroporation.
Valerio M., Ahmed H.U., Emberton M., 2015. Techniques in Vascular and Interventional Radiology, 18 (3) pp. 147-152. Peer-reviewed.
 
High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools.
Chevalier M.F., Bobisse S., Costa-Nunes C., Cesson V., Jichlinski P., Speiser D.E., Harari A., Coukos G., Romero P., Nardelli-Haefliger D. et al., 2015. Oncoimmunology, 4 (10) pp. e1029702. Peer-reviewed.
 
Histopathology and prognosis of de novo bladder tumors following solid organ transplantation.
Ederer I.A., Lucca I., Hofbauer S.L., Haidinger M., Haitel A., Susani M., Shariat S.F., Klatte T., 2015. World Journal of Urology, 33 (12) pp. 2087-2093. Peer-reviewed.
 
Identifying the index lesion with template prostate mapping biopsies.
Valerio M., Anele C., Freeman A., Jameson C., Singh P.B., Hu Y., Emberton M., Ahmed H.U., 2015. Journal of Urology, 193 (4) pp. 1185-1190. Peer-reviewed.
 
Kidney-sparing surgery for upper tract urothelial cancer.
Lucca I., Klatte T., Rouprêt M., Shariat S.F., 2015. Current Opinion in Urology, 25 (2) pp. 100-104. Peer-reviewed.
 
Le rapport neutrophiles/lymphocytes est un facteur prédictif indépendant de récidive et de progression dans les tumeurs de vessie non infiltrantes. [Not Available]
Mbeutcha A., Lucca I., De Martino M., Mathieu R., Rieken M., Xylinas E., Kluth L., Crivelli J., Lotan Y., Shariat S. et al., 2015. Progrès En Urologie : Journal De L'association Française D'urologie et De La Société Française D'urologie, 25 (13) pp. 759-760. Peer-reviewed.
Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.
Domingos-Pereira S., Hojeij R., Reggi E., Derré L., Chevalier M.F., Romero P., Jichlinski P., Nardelli-Haefliger D., 2015. Oncoimmunology, 4 (7) pp. e1016697. Peer-reviewed.
 
Methodological considerations in assessing the utility of imaging in early prostate cancer.
Valerio M., Willis S., van der Meulen J., Emberton M., Ahmed H.U., 2015. Current Opinion in Urology, 25 (6) pp. 536-542. Peer-reviewed.
 
MRI/TRUS fusion software-based targeted biopsy: the new standard of care?
Manfredi M., Costa Moretti T.B., Emberton M., Villers A., Valerio M., 2015. Minerva Urologica e Nefrologica, 67 (3) pp. 233-246. Peer-reviewed.
 
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.
Mathieu R., Shariat S.F., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y., Scherr D.S., Tewari A., Montorsi F. et al., 2015. World Journal of Urology, 33 (8) pp. 1165-1171. Peer-reviewed.
 
Novel biomarkers to predict response and prognosis in localized bladder cancer.
Lucca I., de Martino M., Klatte T., Shariat S.F., 2015. Urologic Clinics of North America, 42 (2) pp. 225-33, ix. Peer-reviewed.
 
Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis.
Lucca I., Shariat S.F., Hofbauer S.L., Klatte T., 2015. World Journal of Urology, 33 (4) pp. 563-570. Peer-reviewed.
Preoperative nutritional screening by the specialist instead of the nutritional risk score might prevent excess nutrition: a multivariate analysis of nutritional risk factors.
Grass F., Hübner M., Schäfer M., Ballabeni P., Cerantola Y., Demartines N., Pralong F.P., Bertrand P.C., 2015. Nutrition Journal, 14 (1) p. 37. Peer-reviewed.
 
The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma.
Hofbauer S.L., Pantuck A.J., de Martino M., Lucca I., Haitel A., Shariat S.F., Belldegrun A.S., Klatte T., 2015. Urologic Oncology, 33 (2) pp. 68.e1-68.e7. Peer-reviewed.
 
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
Lucca I., Kassouf W., Kapoor A., Fairey A., Rendon R.A., Izawa J.I., Black P.C., Fajkovic H., Seitz C., Remzi M. et al., 2015. BJU International, 116 (1) pp. 72-78. Peer-reviewed.
 
The T309G Murine Double Minute 2 Gene Polymorphism Is an Independent Prognostic Factor for Patients with Renal Cell Carcinoma.
de Martino M., Taus C., Wessely I.S., Lucca I., Hofbauer S.L., Haitel A., Shariat S.F., Klatte T., 2015. Dna and Cell Biology, 34 (2) pp. 107-112. Peer-reviewed.
 
Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
Mathieu R., Lucca I., Klatte T., Babjuk M., Shariat S.F., 2015. Current Opinion In Urology, 25 (5) pp. 476-482. Peer-reviewed.
Upper urinary tract disease: what we know today and unmet needs
Mathieu , Bensalah , Lucca , Mbeutcha , Rouprêt , Shariat , 2015. Translational Andrology and Urology, 4 (3) pp. 261-272. Peer-reviewed.
 
Urologie [Urology].
Boldini M., Cerantola Y., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (456-457) pp. 143-147.
 
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
Lucca I., Shariat S.F., Briganti A., Lotan Y., Roehrborn C.G., Montorsi F., Remzi M., Seitz C., Fajkovic H., Klingler C. et al., 2015. Urologic Oncology, 33 (2) pp. 71.e21-71.e26. Peer-reviewed.
 
Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer.
Valerio M., McCartan N., Freeman A., Punwani S., Emberton M., Ahmed H.U., 2015. Urologic Oncology, 33 (10) pp. 424.e9-424.16.
A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
Valerio M., Dickinson L., Ali A., Ramachandran N., Donaldson I., Freeman A., Ahmed H.U., Emberton M., 2014. Contemporary Clinical Trials, 39 (1) pp. 57-65.
Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig cells and adult human testis.
Vaucher L., Funaro M.G., Mehta A., Mielnik A., Bolyakov A., Prossnitz E.R., Schlegel P.N., Paduch D.A., 2014. Plos One, 9 (4) pp. e92425.
Associations Between Presenting Symptoms, Clinicopathological Parameters, and Prognosis in a Contemporary Series of Patients With Renal Cell Carcinoma
Hofbauer S.L., de Martino M., Seemann C., Zamani N., Lucca I., Haitel A., Shariat S.F., Klatte T., 2014. Korean Journal of Urology, 55 (8) pp. 505-510. Peer-reviewed.
 
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P., 2014. Canadian Urological Association Journal, 8 (9-10) pp. E600-E604. Peer-reviewed.
 
Defining the level of evidence for technology adoption in the localized prostate cancer pathway.
Valerio M., El-Shater Bosaily A., Emberton M., Ahmed H.U., 2014. Urologic Oncology, 32 (6) pp. 924-930. Peer-reviewed.
 
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?
Patel H.R., Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Müller S., Baldini G. et al., 2014. European Urology, 65 (2) pp. 263-266.
Focal therapy will become a standard option for selected men with localized prostate cancer.
Valerio M., Emberton M., Ahmed H.U., 2014. Journal of Clinical Oncology, 32 (32) pp. 3680-3681. Peer-reviewed.
 
Fungus ball in the urinary tract: A rare entity.
Praz V., Burruni R., Meid F., Wisard M., Jichlinski P., Tawadros T., 2014. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 8 (1-2) pp. E118-E120.
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.
Vasilevsky S., Greub G., Nardelli-Haefliger D., Baud D., 2014. Clinical Microbiology Reviews, 27 (2) pp. 346-370.
 
Health technology assessment in evolution - focal therapy in localised prostate cancer.
Valerio M., Emberton M., Barret E., Eberli D., Eggener S.E., Ehdaie B., Jichlinski P., Ward J.F., Ahmed H.U., 2014. Expert Review of Anticancer Therapy, 14 (11) pp. 1359-1367. Peer-reviewed.
Immunotherapeutic strategies for bladder cancer.
Chevalier M.F., Nardelli-Haefliger D., Domingos-Pereira S., Jichlinski P., Derré L., 2014. Human Vaccines and Immunotherapeutics, 10 (4) pp. 977-981. Peer-reviewed.
 
In vivo measurement of tissue oxygenation by time-resolved luminescence spectroscopy: advantageous properties of dichlorotris(1, 10-phenanthroline)-ruthenium(II) hydrate.
Huntosova V., Gay S., Nowak-Sliwinska P., Rajendran S.K., Zellweger M., van den Bergh H., Wagnières G., 2014. Journal of Biomedical Optics, 19 (7) p. 77004. Peer-reviewed.
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.
Valerio M., Stricker P.D., Ahmed H.U., Dickinson L., Ponsky L., Shnier R., Allen C., Emberton M., 2014. Prostate Cancer and Prostatic Diseases, 17 (4) pp. 343-347. Peer-reviewed.
Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.
Domingos-Pereira S., Derré L., Warpelin-Decrausaz L., Haefliger J.A., Romero P., Jichlinski P., Nardelli-Haefliger D., 2014. Journal of Urology, 191 (3) pp. 814-822.
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.
Weiss A., van Beijnum J.R., Bonvin D., Jichlinski P., Dyson P.J., Griffioen A.W., Nowak-Sliwinska P., 2014. Journal of Cellular and Molecular Medicine, 18 (3) pp. 480-491. Peer-reviewed.
 
Optical spectroscopy of the bladder washout fluid to optimize fluorescence cystoscopy with Hexvix®.
Martoccia C., Zellweger M., Lovisa B., Jichlinski P., van den Bergh H., Wagnières G., 2014. Journal of Biomedical Optics, 19 (9) p. 97002. Peer-reviewed.
Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.
Kilarski W.W., Muchowicz A., Wachowska M., Mężyk-Kopeć R., Golab J., Swartz M.A., Nowak-Sliwinska P., 2014. Angiogenesis, 17 (2) pp. 347-357. Peer-reviewed.
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
Hofbauer S.L., Stangl K.I., de Martino M., Lucca I., Haitel A., Shariat S.F., Klatte T., 2014. British Journal of Cancer, 111 (8) pp. 1526-1531. Peer-reviewed.
 
Re: jarow et Al.: drug and device development for localized prostate cancer: report of a food and drug administration/american urological association public workshop (urology 2014;83:975-979).
Valerio M., Emberton M., Ahmed H.U., 2014. Urology, 84 (3) pp. 732-733.
 
Re: tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?: f. Cornud, g. Khoury, N. Bouazza, f. Beuvon, m. Peyromaure, T. Flam, m. Zerbib, p. Legmann and N. B. Delongchamps j urol 2014; 191: 1272-1279.
Valerio M., Ahmed H.U., 2014. Journal of Urology, 192 (4) pp. 1297-1298.
 
Restoration of connexin 40 (cx40) in Renin-producing cells reduces the hypertension of cx40 null mice.
Le Gal L., Alonso F., Wagner C., Germain S., Nardelli Haefliger D., Meda P., Haefliger J.A., 2014. Hypertension, 63 (6) pp. 1198-1204. Peer-reviewed.
 
Sex steroids and gender differences in nonmuscle invasive bladder cancer.
Lucca I., Fajkovic H., Klatte T., 2014. Current Opinion In Urology, 24 (5) pp. 500-505. Peer-reviewed.
 
T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection.
Weiss L., Chevalier M.F., Assoumou L., Didier C., Girard P.M., Piketty C., Costagliola D., Rouzioux C., ANRS 116 SALTO Study Group, 2014. Aids (london, England), 28 (11) pp. 1683-1687. Peer-reviewed.
The role of focal therapy in the management of localised prostate cancer: a systematic review.
Valerio M., Ahmed H.U., Emberton M., Lawrentschuk N., Lazzeri M., Montironi R., Nguyen P.L., Trachtenberg J., Polascik T.J., 2014. European Urology, 66 (4) pp. 732-751. Peer-reviewed.
 
Thérapie focale du cancer de la prostate: rationnel, résultats et perspectives [Focal therapy in prostate cancer: rationale, results and perspectives].
Valerio M., Benamran D., Tawadros T., Cerantola Y., Meuwly J.Y., Lutchmaya-Flick C., Lhermitte B., Wirth G., Iselin C., Jichlinski P., 2014. Revue Médicale Suisse, 10 (453) pp. 2306-2310. Peer-reviewed.
 
Urologie [Urology].
Jichlinski P., 2014. Revue Médicale Suisse, 10 (412-413) pp. 127-129.
 
Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer.
Lucca I., Klatte T., Shariat S.F., 2014. European Urology, 66 (2) pp. 386-387. Peer-reviewed.
 
Are patients at nutritional risk more prone to complications after major urological surgery?
Cerantola Y., Valerio M., Hubner M., Iglesias K., Vaucher L., Jichlinski P., 2013. Journal of Urology, 190 (6) pp. 2126-2132.
 
Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?
Cerantola Y., Valerio M., Kawkabani Marchini A., Meuwly J.Y., Jichlinski P., 2013. Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada, 7 (11-12) pp. E699-E703. Peer-reviewed.
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
Corgnac S., Perret R., Derré L., Zhang L., Stirnemann K., Zauderer M., Speiser D.E., Mach J.P., Romero P., Donda A., 2013. Cancer Immunology, Immunotherapy, 62 (4) pp. 747-760.
 
Centre de la prostate: une approche multidisciplinaire pour une prise en charge globale du patient [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer]
Tawadros T., Burruni R., Herrera F., Codeluppi C., Zurkinden C., Meuwly J.Y., Lhermitte B., Berthold D., 2013. Revue Médicale Suisse, 9 (409) pp. 2270-2, 2274.
CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.
Thibult M.L., Rivals J.P., Mamessier E., Gertner-Dardenne J., Pastor S., Speiser D.E., Derré L., Olive D., 2013. Journal of Molecular Medicine, 91 (2) pp. 195-205.
 
Deep vein thrombosis of the penis: an unusual but severe complication of prostatic abscess.
Calanca L., Alatri A., Schaller M.D., Sermier A., Mazzolai L., 2013. Vasa. Zeitschrift Für Gefässkrankheiten, 42 (3) pp. 214-217.
 
Experimental evaluation of an electromechanical artificial urinary sphincter in an animal model.
Valerio M., Jichlinski P., Dahlem R., Tozzi P., Mundy A.R., 2013. BJU International, 112 (4) pp. E337-E343.
 
Guidelines for perioperative care after radical cystectomy for bladder cancer: enhanced Recovery After Surgery (ERAS(®)) society recommendations.
Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Muller S., Baldini G., Carli F. et al., 2013. Clinical Nutrition, 32 (6) pp. 879-887. Peer-reviewed.
 
Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature.
Rink M., Babjuk M., Catto J.W., Jichlinski P., Shariat S.F., Stenzl A., Stepp H., Zaak D., Witjes J.A., 2013. European Urology, 64 (4) pp. 624-638.
 
Immunothérapie: une nouvelle arme contre le cancer de la prostate [Immunotherapy: a therapeutic revolution against prostate cancer?].
Pracht M., Herrera F., Tawadros T., Berthold D., 2013. Revue Médicale Suisse, 9 (387) pp. 1070-1075.
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.
Decrausaz L., Pythoud C., Domingos-Pereira S., Derré L., Jichlinski P., Nardelli-Haefliger D., 2013. Oncoimmunology, 2 (1) pp. e22944.
 
Intérêt d'une Consultation spécialisée multidisciplinaire en neuro-urologie et urologie fonctionnelle [Benefit of a specialized multidisciplinary clinic in neuro-urology and functional urology].
Tawadros C., Tawadros T., Julita L., Jichlinski P., Schurch B., 2013. Revue Médicale Suisse, 9 (409) pp. 2286-2288.
 
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data.
Burger M., Grossman H.B., Droller M., Schmidbauer J., Hermann G., Drăgoescu O., Ray E., Fradet Y., Karl A., Burgués J.P. et al., 2013. European Urology, 64 (5) pp. 846-854.
 
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T., Alonso F., Jichlinski P., Clarke N., Calandra T., Haefliger J.A., Roger T., 2013. Endocrine-Related Cancer, 20 (1) pp. 137-149.
 
Rétablissement postopératoire optimisé, applique aux patients après cystectomie [Enhanced recovery after surgery applied to cystectomy patients].
M'Baya O., Vlamopoulos Y., Hubner M., Blanc C., Jichlinski P., Cerantola Y., 2013. Revue Médicale Suisse, 9 (409) pp. 2279-82, 2284-5. Peer-reviewed.
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.
Nazarov A.A., Baquié M., Nowak-Sliwinska P., Zava O., van Beijnum J.R., Groessl M., Chisholm D.M., Ahmadi Z., McIndoe J.S., Griffioen A.W. et al., 2013. Scientific Reports, 3 (1485) pp. 1-7.
 
Urologie."Revisitons la prostate!" [Urology. Trends in prostatic diseases in 2012].
Jichlinski P., 2013. Revue Médicale Suisse, 9 (369) pp. 147-149.
 
Vaccination route matters for mucosal tumors.
Nardelli-Haefliger D., Dudda J.C., Romero P., 2013. Science Translational Medicine, 5 (172) pp. 172fs4.
 
An unusual phyllodes tumour of the prostate (FP17)
Fontanella S., Fritschi U., Jichlinski P., deLeval L., Rotman S., 2012/11., 78. Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, 8.-10. November 2012 pp. 575-576 dans Der Pathologe, Springer Medizin.
 
Finasteride-related Leydig cell tumour: report of a case and literature review.
Berthold D., Lhermitte B., Uffer M., Doerfler A., 2012/05. Andrologia, 44 Suppl 1 pp. 836-837.
 
Angiogenesis inhibition for the improvement of photodynamic therapy: The revival of a promising idea.
Weiss A., Van den Bergh H., Griffioen A.W., Nowak-Sliwinska P., 2012. Biochimica et Biophysica Acta, 1826 (1) pp. 53-70.
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.
Nowak-Sliwinska P., Weiss A., Beijnum J.R., Wong T.J., Ballini J.P., Lovisa B., van den Bergh H., Griffioen A.W., 2012. Journal of Cellular and Molecular Medicine, 16 (7) pp. 1553-1562.
 
Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'
Golka Klaus, Abreu-Villaca Yael, Anbari Attar Rowshanak, Angeli-Greaves Miriam, Aslam Muhammad, Basaran Nursen, Belik Rouslana, Butryee Chaniphun, Dalpiaz Orietta, Dzhusupov Keneshbek et al., 2012. Frontiers in Bioscience (Elite edition), 4 (8) pp. 2809-2822. Peer-reviewed.
Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.
Pieraerts C., Martin V., Jichlinski P., Nardelli-Haefliger D., Derre L., 2012. Oncoimmunology, 1 (5) pp. 694-698.
 
International collaborative proficiency study of Human Papillomavirus type 16 serology.
Eklund C., Unger E.R., Nardelli-Haefliger D., Zhou T., Dillner J., 2012. Vaccine, 30 (2) pp. 294-299.
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2012. Mucosal Immunology, 6 (2) pp. 393-404.
 
L'Evidence-based nursing, un levier au changement des pratiques infirmières [Evidence-based nursing, a driver for change in nursing practice].
Codeluppi C., Silva J., Perrenoud B., 2012. Soins 771 pp. 31-33.
Percutaneous drainage and sclerotherapy as definitive treatment of renal lymphangiomatosis.
Valerio M., Meuwly J.Y., Tawadros C., Jichlinski P., 2012. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 6 (1) pp. E3-E7.
 
Preoperative immunonutrition in patients at nutritional risk: results of a double-blinded randomized clinical trial.
Hübner M., Cerantola Y., Grass F., Bertrand P.C., Schäfer M., Demartines N., 2012. European Journal of Clinical Nutrition, 66 (7) pp. 850-855.
SITC 26th annual meeting - summary.
Romano E., Nardelli-Haefliger D., Donda A., Corgnac S., Romero P., 2012. Journal of Translational Medicine, 10 (1) p. 105.
 
Troubles sexuels masculins et obésité [Male sexual dysfunction and obesity].
Lucca I., Paduch D.A., Pralong F., Vaucher L., 2012. Revue Médicale Suisse, 8 (365) pp. 2327-2330.
 
Urologie [Urology in 2011].
Jichlinski P., 2012. Revue Médicale Suisse, 8 (323) pp. 61-63.
What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?
Nardelli-Haefliger D., Romero P., Jichlinski P., 2012. Oncoimmunology, 1 (2) pp. 242-243.
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
 
A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.
Longet S., Schiller J.T., Bobst M., Jichlinski P., Nardelli-Haefliger D., 2011. Journal of Virology, 85 (24) pp. 13253-13259.
 
A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.
Decrausaz L., Gonçalves A.R., Domingos-Pereira S., Pythoud C., Stehle J.C., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 128 (9) pp. 2105-2113.
 
Animal Tissue Response To Mid-Term Electronic Modular Artificial Sphincter Implantation
Valerio M., Jichlinski P., Dahlem R., Wieland M., Tozzi P., Hayoz D., Mundy A.R., 2011. pp. e39, A92 dans AUA 2011,, Journal of Urology. Peer-reviewed.
 
Combined radiohormonotherapy in node positive lymph node prostate cancer
Herrmann E., Boujelbene N., Ozsahin M., Khanfir K., Mirimanoff R.O., Jichlinski P., Gygi C., Zouhair A., 2011. p. 537 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
 
Contrôle de qualité en urologie [Quality assessment in urology].
Cerantola Y., Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2382-2387.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University